SavedAdd your journal

Journals / Klinik Tıp Bilimleri / 2017 / Cilt: 5 - Sayı: 5

Treatment Objectives: How Much Acceptable?

Tedavi Hedefleri: Ne Kadar Kabul Edilebilir?

Dr. Öner ÖZDOĞAN
Pages
15–17
Publication Date
2017-05-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ESCand ACC/AHA hypertension guidelines recommended <140/90 mmHg BP levels in mosthypertensive patients and < 150/90 mmHg levels in older patients as BP target levels.However, novel randomized trials and some meta-analysis revealed some supporting dataof lower BP levels in high risk and older patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractBlood pressure goals in hypertension treatment alter frequently.
📊
Key Findings & Data:It is not certain tostart anti-hypertensive treatment in patients with lower BP levels and co-morbidities.
💡
Conclusion & Impact:ESCand ACC/AHA hypertension guidelines recommended <140/90 mmHg BP levels in mosthypertensive patients and < 150/90 mmHg levels in older patients as BP target levels.However, novel randomized trials and some meta-analysis revealed some supporting dataof lower BP levels in high risk and older patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hipertansiyon · yaşlı hastalar · yüksek riskli hastalar

Abstract

AbstractBlood pressure goals in hypertension treatment alter frequently. It is not certain tostart anti-hypertensive treatment in patients with lower BP levels and co-morbidities. ESCand ACC/AHA hypertension guidelines recommended <140/90 mmHg BP levels in mosthypertensive patients and < 150/90 mmHg levels in older patients as BP target levels.However, novel randomized trials and some meta-analysis revealed some supporting dataof lower BP levels in high risk and older patients.

Özet

ÖzHipertansiyon tedavisinde kan basıncı (KB) hedefleri devamlı değişmektedir. Ko-morbiditesi olan ve daha düşük KB değerleri olan hastalarda tedavi başlanmasının faydaları net değildir. ESC ve ACC/AHA hipertansiyon rehberleri çoğu hipertansif hastada <140/90mmHg, yaşlılarda ise <150/90 mmHg değerleri hedef KB değerleri olarak önermekte-dir. Fakat, yeni randomize çalışmalar ve bazı meta-analizler yüksek riskli ve yaşlı kişilerde daha düşük KB değerlerini destekleyen bazı veriler ortaya koymuştur.

🔖

Cite This Article

ÖZDOĞAN, D. Ö. (2017). Treatment Objectives: How Much Acceptable?. Klinik Tıp Bilimleri, Cilt: 5 - Sayı: 5, 15–17. https://ajindex.com/articles/838252

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kaynaklar 1-Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, BirkenhägerWH, et al. Randomised double-blind comparison of placebo and ac-tive treatment for older patients with isolated systolic hypertension.The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Lancet. 1997 Sep 13
  2. 350(9080):757-64. 2-Prevention of stroke by antihypertensive drug treatment in older per-sons with isolated systolic hypertension. Final results of the Systo-lic Hypertension in the Elderly Program (SHEP). SHEP Coopera-tive Research Group.[No authors listed] JAMA. 1991 Jun26
  3. 265(24):3255-64. 3-Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP, INDANAProject Steering Committee. INdividual Data ANalysis of Antihyper-tensive intervention J-shaped relationship between blood pressureand mortality in hypertensive patients: new insights from a meta-analy-sis of individual-patient data. Ann Intern Med. 2002
  4. 136(6):438. 4-Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, FletcherA, et al. Relation between mortality and treated blood pressure inelderly patients with hypertension: report of the European WorkingParty on High Blood Pressure in the Elderly. BMJ.1989
  5. 298(6687):1552. 5-Arguedas JA, Perez MI, Wright JM. Treatment blood pressure tar-gets for hypertension. Cochrane Database Syst Rev. 2009 Jul 8
  6. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr,Cutler JA, et al. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr29
  7. 362(17):1575-85 7-Sundström J, Arima H, Woodward M, Jackson R, Karmali K, Lloyd-Jones D, et al. Blood Pressure Lowering Treatment Trialists' Col-laboration. Blood pressure-lowering treatment based on cardiovas-cular risk: a meta-analysis of individual patient data. Lancet. 2014Aug 16
  8. 384(9943):591-8. 8-Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shima-da K, et al. Valsartan in Elderly Isolated Systolic Hypertension StudyGroup. Hypertension. 2010 Aug
  9. 56(2):196-202. 9-Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Roc-co MV, et al. A Randomized Trial of Intensive versus Standard Blo-od-Pressure Control. SPRINT Research Group. N Engl J Med.2015
  10. 373(22):2103. 10-SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK,Snyder JK, Sink KM, Rocco MV et al. A Randomized Trial of Inten-sive versus Standard Blood-Pressure Control N Engl J Med 2015
  11. 2116 10, 26, 2015 11-Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T et al. Effectso